Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07527143) titled 'Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer' on April 7.
Study Type: Observational
Primary Sponsor: Mayo Clinic
Condition:
Endometrial Carcinoma
Intervention:
Other: Non-Interventional Study
Recruitment Status: Not recruiting
Date of First Enrollment: April 6, 2026
Target Sample Size: 25
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07527143
Disclaimer: Curated by HT Syndication....